ccd, I think that would have an immediate positive impact on the share price if they put in someone with a biotech business background and someone who is honest to and respects retail share holders. That type of person would immediately attract analyst coverage and raise the RVX/apabetalone profile.

The apabetalone story is such an exciting story that even a PR student in a co-op program could have the good news all over the media in a week.

Don could remain COB although that would detract from the RVX equity IMHO.

GLTA

Toinv